- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
- Details
- Written by AHA
- Category: Health News
Anaheim, California - A combination of reduced sodium intake and the DASH diet lowers blood pressure in adults with hypertension, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
- Details
- Written by American Heart Association
- Category: Health News
Anaheim, California - Latinos are less likely to know what an automated external defibrillator (AED) is and who can use it, which could affect outcomes of sudden cardiac arrests in Latino neighborhoods, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
- Details
- Written by Megan Forliti
- Category: Health News
Rochester, Minnesota - Families living with Alzheimer's disease woke to devastating newspaper headlines recently: Another highly touted drug failed in clinical trials.
- Details
- Written by CDC
- Category: Health News
Washington, DC - About 1 in 5 U.S. adults used some form of tobacco product in 2015, according to new data published by the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products in the Morbidity and Mortality Weekly Report (MMWR).
- Details
- Written by Ian Roth
- Category: Health News
Scottsdale, Arizona - With more than 30 million Americans and 500 million people worldwide diagnosed with Type 2 diabetes, Dr. Robert Rizza, a Mayo Clinic endocrinologist, says it's time to start calling Type 2 diabetes an epidemic. He says the fact that people are being diagnosed at younger ages more commonly than ever only strengthens the argument that the world is facing an epidemic.
Page 58 of 374
